🇺🇸 FDA
Patent

US 12178848

Methods and compositions for the treatment of exocrine pancreatic insufficiency

granted A61KA61K38/1825A61K9/0019

Quick answer

US patent 12178848 (Methods and compositions for the treatment of exocrine pancreatic insufficiency) held by The Board of Regents of the University of Texas System expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/1825, A61K9/0019, A61K9/0053, A61P